Skip to content

IQVIA Holdings

US · IQV #493 by market cap Listed 1970
245.82 -4.73 -1.89%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q4).
  • Total institutional ownership (as a % of shares) was little changed.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
101.92% -0.04pp
Institutions
1,469 -4
As of
2026/Q4 vs. prior period

Holder types

Mutual Fund81.06%
Hedge Fund6.50%
Government4.10%
Public Company3.68%
Private Company1.93%
Government Pension Fund1.80%
Sovereign Wealth Fund1.46%
Individual/Insider0.97%
Family Office/Trust0.63%

Top holders as of 2026-09-30

BlackRock 8.76% · 14.43M sh
Vanguard Capital Management, LLC 7.10% · 11.71M sh
Harris Associates L.P. 6.34% · 10.45M sh
State Street Global Advisors 4.56% · 7.52M sh
Vanguard Portfolio Management, LLC 4.47% · 7.36M sh
Singapore 3.97% · 6.54M sh
Geode Capital Management, LLC 2.69% · 4.43M sh
Boston Partners Global Investors, Inc. 2.65% · 4.37M sh
Artisan Partners Limited Partnership 2.10% · 3.46M sh
J.P. Morgan Asset Management, Inc. 2.02% · 3.33M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 37 buys · 13 sells

NameRoleStake
Ari Bousbib Chairperson & CEO 0.84%
Ronald Bruehlman Former Chief Financial Officer 0.03%
John Danhakl Independent Director 0.02%
Alistair Grenfell President of Commercial Solutions 0.01%
Eric Sherbet General Counsel 0.01%
Bernard Haas Former Executive Vice President of AI & Technology Solutions 0.01%
John Leonard Lead Independent Director 0.01%
Colleen Goggins Independent Director 0.01%
W. Staub President of Research & Development Solutions 0.01%
James Berkshire Executive Vice President of Global Infrastructure & Operations 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-08 Eric Sherbet General Counsel Derivative Exercise and Sale -8,436 $131.82–278.83
2026-11-04 John Danhakl Independent Director Other Derivative Acquisition +134 --
2026-11-04 Leslie Morris Independent Director Other Derivative Acquisition +125 --
2026-11-04 Colleen Goggins Independent Director Other Derivative Acquisition +144 --
2026-11-04 James Fasano Independent Director Other Derivative Acquisition +154 --
2026-09-01 James Berkshire Executive Vice President of Global Infrastructure & Operations Derivative Exercise and Sale -5,381 $131.82–261.54
2026-08-02 W. Staub President of Research & Development Solutions Open Market Disposition -5,500 $232.68
2026-07-30 Bhavik Patel President of MedTech & Consumer Health Open Market Disposition -1,855 $235.27
2026-07-28 Ari Bousbib Chairperson & CEO Derivative Exercise and Sale -156,206 $78.21–247.10
2026-07-28 Eric Sherbet General Counsel Open Market Disposition -5,000 $249.16
2026-07-28 Keriann Cherofsky Senior VP, Corporate Controller & Chief Accounting Officer Open Market Disposition -558 $245.21
2026-07-13 John Danhakl Independent Director Other Derivative Acquisition +160 --
2026-07-13 Leslie Morris Independent Director Other Derivative Acquisition +148 --
2026-07-13 Colleen Goggins Independent Director Other Derivative Acquisition +183 --
2026-07-13 James Fasano Independent Director Other Derivative Acquisition +195 --
2026-05-06 John Danhakl Independent Director Other Derivative Acquisition +185 --
2026-05-06 Leslie Morris Independent Director Other Derivative Acquisition +171 --
2026-05-06 Colleen Goggins Independent Director Other Derivative Acquisition +214 --
2026-05-06 James Fasano Independent Director Other Derivative Acquisition +228 --
2026-04-22 John Danhakl Independent Director Other Acquisition +1,571 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

IQVIA Holdings discussion 0 comments

Add a comment